In addition, both mock challenge and KAg+Poly(I:C) vaccinates also exhibited a significant reduction in the challenge virus titers compared to Nano-11-KAg vaccinates at DPC6 ( Figure 2C )

In addition, both mock challenge and KAg+Poly(I:C) vaccinates also exhibited a significant reduction in the challenge virus titers compared to Nano-11-KAg vaccinates at DPC6 ( Figure 2C ). to both H1N2 and H1N1 SwAIV. In commercial vaccinates, activated H1N2- and H1N1-specific IFN+&TNF+, IL-17A+ and central memory T-helper/Memory cells, and in Continue Reading